regn industry pharmaceuticals ; biotech founded 1988 headquarters tarrytown new york us headquarters area served worldwide key people leonard schleifer ceo george yancopoulos cso revenue 4.1 billion 1 net income 1.4 billion 1 total assets 5.6 billion 1 website www.regeneron.com regeneron pharmaceuticals inc. is a biotechnology company headquartered in tarrytown new york . the company was founded in 1988 . 2 originally focused on neurotrophic factors and their regenerative capabilities thus the name it branched out into the study of both cytokine and tyrosine kinase receptors . contents 1 company history 2 marketed products 3 technology platforms 4 financial performance 5 references 6 external links company history edit regeneron has two products in development based on aflibercept a vegf inhibitor and rilonacept an interleukin 1 blocker . vegf is a protein that normally stimulates the growth of blood vessels and interleukin 1 is a protein that is normally involved in inflammation . on march 26 2012 bloomberg announced that sanofi and regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72 % more than the leading brands . it is believed this new drug will greatly reduce heart disease in patients around the world . the medicine one in a class of drugs targeting the pcsk9 gene reduced patients average ldl cholesterol levels to as little as 34 milligrams per deciliter after 12 weeks in the mid stage study presented on march 2012 at the american college of cardiology meeting in chicago . citation needed in july 2015 the company announced a new global collaboration with sanofi to discover develop and commercialise new immuno oncology drugs which could generate more than 2 billion for regeneron 3 with 640 million upfront 750 million for proof of concept data and 650 million from the development of regn2810 . 4 marketed products edit eylea aflibercept injection approved by the u.s. food and drug administration fda in november 2011 . 2 5 eylea developed to treat a common cause of blindness in the elderly . arcalyst rilonacept for specific rare autoinflammatory conditions . approved by the fda in february 2008 . zaltrap aflibercept injection for metastatic colorectal cancer approved by the fda in august 2012 . 6 praluent alirocumab indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease ascvd who require additional lowering of low density lipoprotein ldl cholesterol . approved by fda on 24 july 2015 7 technology platforms edit trap fusion proteins regeneron s novel and patented trap technology creates high affinity product candidates for many types of signaling molecules including growth factors and cytokines . the trap technology involves fusing two distinct fully human receptor components and a fully human immunoglobulin g constant region . fully human monoclonal antibodies regeneron has developed a suite velocisuite of patented technologies including velocimmune and velocimab that allow regeneron scientists to determine the best targets for therapeutic intervention and rapidly generate high quality fully human antibodies drug candidates addressing these targets . 8 255 258 financial performance edit financial year revenue ref 2012 1.4 billion 9 2013 2.1 billion 10 2014 2.8 billion 1 2015 4.1 billion 1 references edit a b c d e http files.shareholder.com downloads regn 2773703469x0x873937 63301ccd a156 46ce 8521 64d7984e3107 regn news 2016 2 9 general releases.pdf a b herper matthew august 14 2013 . how two guys from queens are changing drug discovery . forbes . united states . archived from the original on march 16 2014 . retrieved march 22 2014 . regeneron sanofi launch 2b immuno oncology collaboration gen news highlights gen . updated struggling sanofi paying 1.8 b to partner with regeneron on immuno oncology fiercebiotech . regulators approve a drug for an eye condition . the new york times . associated press . november 18 2011 . registration required fda approves zaltrap for metastatic colorectal cancer press release . u.s. food and drug administration . august 3 2012 . archived from the original on june 25 2013 . http www.fda.gov newsevents newsroom pressannouncements ucm455883.htm susana magad n momp and frica gonz lez fern ndez . human monoclonal antibodies from transgenic mice . chapter 13 in human monoclonal antibodies methods and protocols ed . michael steinitz . springer science business media 2014 . isbn 978 1 62703 585 9 regeneron pharmaceuticals inc 2013 annual report form 10 k xbrl . united states securities and exchange commission . february 13 2014 . regeneron pharmaceuticals inc 2013 annual report form 10 k xbrl . united states securities and exchange commission . february 13 2014 . external links edit official website success long in coming for eylea a vision treatment v t e pharmaceutical companies of the united states abbott laboratories acorda therapeutics actavis aderis pharmaceuticals adolor corporation alcon alexion pharmaceuticals alkermes allergan alza amgen amylin pharmaceuticals ariad pharmaceuticals aryx therapeutics avax technologies baxter international biocryst pharmaceuticals biogen biolex biovest biovista bradley pharmaceuticals bristol myers squibb cancervax century pharmaceuticals cephalon ceragenix pharmaceuticals combe incorporated cortex pharmaceuticals cotherix covance covidien cubist pharmaceuticals cutter laboratories cytosport cytrx danco laboratories dnaprint genomics epix pharmaceuticals eli lilly and company elorac endo pharmaceuticals ethicon endo surgery ethicon inc. forest laboratories galena biopharma genvec genentech genta gilead sciences hospira imclone systems institute for oneworld health intercept pharmaceuticals ista pharmaceuticals ivax corporation janssen biotech johnson & johnson kinetic concepts king pharmaceuticals kinray kv pharmaceutical leiner health products mallinckrodt martek biosciences corporation s. e. massengill company mckesson corporation mcneil laboratories melior discovery mentholatum merck & co. miles laboratories mylan myriad genetics naurex nereus pharmaceuticals northwest biotherapeutics norwich pharma services novabay pharmaceuticals nuvelo organon international ortho pharmaceutical ortho mcneil pharmaceutical osi pharmaceuticals ovation pharmaceuticals par pharmaceutical parke davis perrigo pfizer pharmaceutical product development prasco laboratories procter & gamble proteon therapeutics purdue pharma qualitest quark pharmaceuticals regeneron repros therapeutics rib x pharmaceuticals sarepta therapeutics savage laboratories schering plough g. d. searle & company sheffield pharmaceuticals smith kline & french spectrum pharmaceuticals sterling drug tanox tap pharmaceutical products tec laboratories teva pharmaceutical industries tiens biotech group titan pharmaceuticals trevena inc trubion upjohn upsher smith laboratories valeant pharmaceuticals ventria bioscience vertex pharmaceuticals verus pharmaceuticals vion pharmaceuticals inc. viropharma west pharmaceutical services wyeth zonite products corporation list of pharmaceutical companies v t e companies of the nasdaq 100 index 21st century fox activision blizzard adobe systems akamai technologies alexion pharmaceuticals alphabet amazon.com american airlines group amgen analog devices apple applied materials autodesk automatic data processing baidu bed bath & beyond biogen biomarin pharmaceutical broadcom limited ca technologies celgene cerner charter communications check point cisco systems citrix systems cognizant comcast costco csx ctrip.com international discovery communications dish network dollar tree ebay electronic arts endo international expedia express scripts facebook fastenal fiserv gilead sciences henry schein illumina incyte intel intuit intuitive surgical jd.com kraft heinz lam research liberty braves liberty global liberty interactive liberty media linear technology marriott international mattel maxim integrated products micron technology microsoft mondelez international monster beverage mylan netapp netflix norwegian cruise line holdings nvidia nxp semiconductors o reilly automotive paccar paychex paypal qualcomm regeneron ross stores sandisk sba communications seagate technology sirius xm holdings skyworks solutions starbucks stericycle symantec t mobile us tesla motors texas instruments the priceline group tractor supply company tripadvisor ulta salon cosmetics & fragrance verisk analytics vertex pharmaceuticals viacom vodafone walgreens boots alliance western digital whole foods market xilinx yahoo retrieved from https en.wikipedia.org w index.php title regeneron & oldid 744587732 categories companies in the nasdaq 100 indexcompanies listed on nasdaqbiotechnology companies of the united statescompanies in the nasdaq biotechnology indexpharmaceutical companies of the united stateslife sciences industryhidden categories pages with login required references or sourcesall articles with unsourced statementsarticles with unsourced statements from may 2016 navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages deutschfran ais edit links this page was last modified on 16 october 2016 at 06 12 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view